Holen Sie sich die Stockscreener-App
1.76
54.65%
-2.22
Finanzdaten der Prelude Therapeutics Inc-Aktie (PRLD)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | 4.00 | 3.00 | - |
Operating Expenses
|
6.97%
32.19
|
34.61 | 37.83 | 37.38 | 37.16 |
| Operating Income/Loss |
6.97%
-32.19
|
-34.61 | -33.83 | -34.38 | -37.16 |
| Income/Loss From Continuing Operations Before Tax |
2.66%
-31.23
|
-32.09 | -28.73 | 3.00 | -34.74 |
| Income/Loss From Continuing Operations After Tax |
2.66%
-31.23
|
-32.09 | -28.73 | -32.27 | -34.74 |
|
Net Income/Loss
|
2.66%
-31.23
|
-32.09 | -28.73 | -32.27 | -34.74 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.01%
75.99
|
75.99 | 0.0209 | 75.86 | 75.76 |
| Diluted Average Shares |
0.01%
75.99
|
75.99 | 0.0209 | 75.86 | 75.76 |
| Basic Earnings Per Share |
2.38%
-0.41
|
-0.42 | -0.38 | -0.43 | -0.46 |
| Diluted Earnings Per Share |
2.38%
-0.41
|
-0.42 | -0.38 | -0.43 | -0.46 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.21%
1.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):